Status:
UNKNOWN
Medtronic 670G Insulin Pump and the Impact on Glycemic Control, Quality of Life, and Compliance
Lead Sponsor:
Metabolic Research Institute, Inc.
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
Analyze the Medtronic 670g pump on glycemic control
Detailed Description
An Analysis of the Medtronic 670g Insulin pump use in clinical practice and the impact on glycemic control , quality of life, and compliance
Eligibility Criteria
Inclusion
- age 18 or older
- Documented History of Type 1 Diabetes Mellitus
- 3 months continuous use of the Medtronic 670g pump system
- given written informed consent
Exclusion
- Less than 3 months use of the Medtronic 670g pump system
- Taking any other medication, other than the insulin used in the Medtronic 670g pump, to manage their diabetes
- having medical conditions or taking medications that would preclude subject involvement or affect the outcomes being measured, in the opinion of the Investigator
Key Trial Info
Start Date :
March 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 23 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04329871
Start Date
March 24 2020
End Date
March 23 2021
Last Update
April 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Metabolic Research Institute
West Palm Beach, Florida, United States, 33401